Inventor · disambiguated record
Chadwick Terence King
Also filed as: KING CHADWICK · KING CHADWICK T · KING CHADWICK TERENCE
60 granted patents·27 pending applications·1,137 citations·filing 2002–2024
99Inventor score
Files withAMGEN INC49AMGEN FREMONT INC8JACKSON SIMON MARK7KINIKSA PHARMACEUTICALS LTD7WEBER RICHARD5
Top patents by PatentIndex Score
87 records- 0199US8859741B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 14, 2014·51 cites·24 claims
- 0299US8829165B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2013·Granted Sep 9, 2014·76 cites·29 claims
- 0399US8030457B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2008·Granted Oct 4, 2011·175 cites·27 claims
- 0498US8883983B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 11, 2014·26 cites·30 claims
- 0598US8871914B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·25 claims
- 0698US8871913B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·29 claims
- 0798US8563698B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2009·Granted Oct 22, 2013·72 cites·6 claims
- 0898US8168762B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted May 1, 2012·101 cites·22 claims
- 0997US9056915B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Jun 16, 2015·20 cites·23 claims
- 1097US9045547B2Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted Jun 2, 2015·42 cites·66 claims
- 1197US8981064B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Mar 17, 2015·20 cites·29 claims
- 1297US8889834B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 18, 2014·25 cites·20 claims
- 1397US7736644B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Jun 15, 2010·77 cites·115 claims
- 1497US7628986B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Dec 8, 2009·119 cites·83 claims
- 1595US9102731B2Human CGRP receptor binding proteinsBOONE THOMAS C·Filed 2009·Granted Aug 11, 2015·39 cites·15 claims
- 1693US9096672B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Aug 4, 2015·16 cites·38 claims
- 1791US9862771B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2015·Granted Jan 9, 2018·8 cites·36 claims
- 1891US2025129172A1Human cgrp receptor binding proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 1990US10266604B2CD27L antigen binding proteinsAMGEN INC·Filed 2017·Granted Apr 23, 2019·8 cites·22 claims
- 2090US9382318B2ST2 antigen binding proteinsAMGEN INC·Filed 2013·Granted Jul 5, 2016·10 cites·29 claims
- 2190US7318925B2Methods of use for antibodies against parathyroid hormoneAMGEN FREMONT INC·Filed 2004·Granted Jan 15, 2008·30 cites·27 claims
- 2290US7288253B2Antibodies directed to parathyroid hormone (PTH) and uses thereofAMGEN FREMONT INC·Filed 2003·Granted Oct 30, 2007·32 cites·16 claims
- 2389US2025230250A1Oncostatin m receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 2489US2025163160A1Human Antigen Binding Proteins That Bind Beta-Klotho, FGF Receptors and Complexes ThereofAMGEN INC·Filed 2024·Application pending·0 cites
- 2588US11059895B2ST2 antigen binding proteinsAMGEN INC·Filed 2019·Granted Jul 13, 2021·2 cites·38 claims
- 2688US9593163B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2016·Granted Mar 14, 2017·5 cites·16 claims
- 2788US9062113B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jun 23, 2015·7 cites·28 claims
- 2888US7265212B2Anti-CD45RB antibodiesAMGEN FREMONT INC·Filed 2002·Granted Sep 4, 2007·33 cites·8 claims
- 2988US2024368292A1St2 antigen binding proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 3087US10059766B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Aug 28, 2018·9 cites·17 claims
- 3187US9982054B2ST2 antigen binding proteinsAMGEN INC·Filed 2016·Granted May 29, 2018·4 cites·34 claims
- 3286US11028180B2Anti-Jagged1 antigen binding proteinsAMGEN INC·Filed 2018·Granted Jun 8, 2021·2 cites·11 claims
- 3386US9284378B2Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereofHU SHAW-FEN SYLVIA·Filed 2010·Granted Mar 15, 2016·9 cites·3 claims
- 3485US9493576B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 15, 2016·2 cites·43 claims
- 3585US7572444B2Binding proteins specific for human matriptaseAMGEN FREMONT INC·Filed 2005·Granted Aug 11, 2009·12 cites·17 claims
- 3684US9517264B2Human FGF receptor and β-Klotho binding proteinsFACHINI ROGER·Filed 2011·Granted Dec 13, 2016·19 cites·41 claims
- 3784US8987422B2CD27L antigen binding proteinsDELANEY JOHN M·Filed 2012·Granted Mar 24, 2015·7 cites·29 claims
- 3883US9574008B2CD27L antigen binding proteinsAMGEN INC·Filed 2015·Granted Feb 21, 2017·4 cites·23 claims
- 3982US9073998B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Jul 7, 2015·3 cites·88 claims
- 4081US11492411B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2019·Granted Nov 8, 2022·0 cites·20 claims
- 4181US11248052B2Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptorAMGEN INC·Filed 2019·Granted Feb 15, 2022·1 cites·5 claims
- 4281US11053311B2Antibodies targeting CDH19 for melanomaAMGEN INC·Filed 2018·Granted Jul 6, 2021·1 cites·25 claims
- 4381US10118968B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Nov 6, 2018·2 cites·54 claims
- 4481US9663571B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2014·Granted May 30, 2017·3 cites·16 claims
- 4581US2025084160A1Antibodies targeting cdh19 for melanomaAMGEN INC·Filed 2024·Application pending·0 cites
- 4680US9085624B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jul 21, 2015·2 cites·26 claims
- 4779US11498964B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2018·Granted Nov 15, 2022·1 cites·17 claims
- 4878US12441796B2Antibody constructs for CDH19 and CD3AMGEN INC·Filed 2022·Granted Oct 14, 2025·0 cites·17 claims
- 4978US12122837B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2021·Granted Oct 22, 2024·0 cites·28 claims
- 5078US11965029B2ST2 antigen binding proteinsAMGEN INC·Filed 2021·Granted Apr 23, 2024·0 cites·36 claims
Showing the top 50 of 87 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →